1. Home
  2. INAB vs BGI Comparison

INAB vs BGI Comparison

Compare INAB & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.57

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Logo Birks Group Inc.

BGI

Birks Group Inc.

HOLD

Current Price

$0.68

Market Cap

15.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
BGI
Founded
2016
1879
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2M
15.9M
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
INAB
BGI
Price
$1.57
$0.68
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
60.3K
21.4K
Earning Date
05-11-2026
12-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.56
52 Week High
$4.20
$1.57

Technical Indicators

Market Signals
Indicator
INAB
BGI
Relative Strength Index (RSI) 55.75 40.35
Support Level $1.52 $0.64
Resistance Level $2.14 $0.78
Average True Range (ATR) 0.09 0.06
MACD 0.03 -0.01
Stochastic Oscillator 73.28 25.20

Price Performance

Historical Comparison
INAB
BGI

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: